Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.148 USD | 0.00% | +6.47% | -86.81% |
Financials (USD)
Sales 2024 * | 51.5M | Sales 2025 * | 55.5M | Capitalization | 4.92M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-1.35
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.67% |
Latest transcript on BIOLASE, Inc.
1 week | +6.47% | ||
Current month | -22.02% | ||
1 month | -7.67% | ||
3 months | -83.37% | ||
6 months | -91.03% | ||
Current year | -86.81% |
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.148 | 0.00% | 688,002 |
24-04-25 | 0.148 | +2.78% | 626,004 |
24-04-24 | 0.144 | -4.70% | 546,367 |
24-04-23 | 0.1511 | +0.73% | 786,586 |
24-04-22 | 0.15 | +7.91% | 1,455,637 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.81% | 4.92M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- BIOL Stock